INTENT Neural Interface for Paralysis

(INTENT Trial)

This trial tests a new device called the INTENT Neural Interface System, designed to assist individuals with severe movement problems due to conditions like paralysis or ALS, which affects nerve cells in the brain and spinal cord. The device enables participants to control assistive devices using brain signals. Individuals with disabling movement issues in both arms for at least a year, possibly combined with severe speech problems, may qualify. The trial aims to ensure the device's safety and assess its effectiveness in helping those with limited mobility communicate and interact with their surroundings. As an unphased trial, it offers a unique opportunity to contribute to groundbreaking research that could transform lives.

The trial does not specify if you need to stop taking your current medications. However, if you are on chronic anti-coagulation or steroids, you may need to temporarily stop them for surgery.

Research has shown that the INTENT Neural Interface System, a device implanted in people with paralysis, has a promising safety record. Earlier studies of similar devices reported no serious safety issues requiring device removal. Importantly, there were no infections in the brain or nervous system.

The INTENT Neural Interface System is unique because it offers a groundbreaking approach for individuals with paralysis by directly interfacing with the nervous system. Unlike traditional treatments that often focus on physical rehabilitation or assistive devices, this system uses advanced neural technology to potentially restore movement by decoding brain signals and translating them into actions. Researchers are excited about this treatment because it represents a significant leap forward in neurotechnology, with the potential to drastically improve independence and quality of life for those affected by paralysis.

Research has shown that the INTENT Neural Interface System, which participants in this trial will receive, could assist people with paralysis. A similar brain-computer interface (BCI) demonstrated 92% accuracy in reading brain signals to aid user movement. In another study, a BCI enabled a paralyzed person to stand and walk naturally in everyday settings. BCIs have also allowed users to type up to 22 words per minute by thought alone. Safety reports remain positive, with no major issues necessitating device removal. This evidence suggests the INTENT system might help people with paralysis regain some control over their movements.⁶⁷⁸⁹¹⁰